Amneal Pharmaceuticals, Inc.

US$20.14As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AMRXHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR 0.24%
Div yield —
ROE 70.00%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.21
PE TTM 50.47
TSR TTM 86.14%
Mkt cap US$7.015B
ROIC 15.77%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$26
28.28%
(93.73%)
Hold 11|7|1|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.35
0.33
0.33
0.34
13.93%
12.80%
10.91%
9.13%
Revenue$M
455.6
475.9
490.5
485.5
1.46%
7.39%
8.80%
6.99%
Peers (US$7.015B)
Cap (US$)
PE
5.434B
7.363x
Capital
TTM
5Y
10Y
Leveragex
5.160
(0.030)
(0.024)
EBIT/Intx
2.147
0.354
0.329
Own earn%
(63.04)
53.17
58.97
Sh yield%
25.82
47.09
47.20
Owners
Insiders/Inst%
14.27
38.00
Short interest%
1.29
SBC / revenue%
5.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
3–9
$1 testx
0.2
Incr. ROIC%
67